The CompoundAI Team

Computational chemists, machine learning engineers, and translational scientists building the tools to accelerate drug discovery.

Dr. Kevin Park
Dr. Kevin Park
CEO & Co-Founder

Computational chemist with 18 years in drug discovery at major pharma. Holds a PhD in Computational Chemistry from Caltech. Led the original platform development team.

Dr. Nathan Brooks
Dr. Nathan Brooks
CTO & Co-Founder

Machine learning engineer with deep experience in protein structure prediction and molecular dynamics. PhD in Biophysics from Stanford. Previously built ML infrastructure at a major genomics company.

Dr. Anita Sharma
Dr. Anita Sharma
Chief Scientific Officer

15 years in medicinal chemistry at a top-10 pharma company. Led multiple IND filings across oncology and CNS. PhD from University of Michigan. Oversees all discovery programs.

Dr. James Osei
Dr. James Osei
VP Clinical Development

Former clinical program director with experience running Phase I/II trials in oncology and neurology. MD/PhD from Johns Hopkins. Oversees the clinical translation layer and active trial operations.

CompoundAI is based at 280 Second Street, Suite 200, San Francisco, CA 94105.
We're a team of 65 scientists and engineers. We're hiring - contact us if you're interested.

Get in Touch